The presence of maternally derived antibodies (MDA) is of great importance in the immunogenicity of IBD, since the level of these will determine the time of the vaccinal virus replication.
The aim of this trial was to evaluate the safety and the immune response produced by GUMBOHATCH® in comparison to different IBD vaccine technologies when administered in commercial broiler chickens with a high MDA levels.
